PMID- 16950294 OWN - NLM STAT- MEDLINE DCOM- 20061017 LR - 20061115 IS - 0091-6749 (Print) IS - 0091-6749 (Linking) VI - 118 IP - 3 DP - 2006 Sep TI - Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice. PG - 725-33 AB - BACKGROUND: Nishiki-nezumi Cinnamon/Nagoya (NC/Nga) mice raised in nonair-controlled conventional circumstances spontaneously develop atopic dermatitis-like skin lesions; however, the underlying mechanisms remain unclear. OBJECTIVE: We wanted to identify the critical intracellular signaling molecules in T cells that induce atopic dermatitis-like skin legions in NC/Nga mice. METHODS: We examined the levels of signal transduction and cytokine production in T cells, particularly those in atopic dermatitis-like lesions induced by the topical injection of mite antigens in NC/Nga mice under specific pathogen-free conditions. RESULTS: In NC/Nga mice maintained under specific pathogen-free conditions, the capability of T(H)1/T(H)2 and T cytotoxic 1/T cytotoxic 2 (Tc1/Tc2) cell differentiation increased significantly. T-cell antigen receptor-mediated activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase cascade and nuclear factor-kappaB (NF-kappaB) signaling were enhanced in NC/Nga T cells. The expression of T(H)2 cytokines (IL-4, IL-13, and IL-5) and that of GATA-binding protein 3 (GATA3), avian musculoaponeurotic fibrosarcoma (c-Maf), NF-kappaB, and activator protein 1 (AP1) selectively increased in draining lymph node T cells of NC/Nga mice. Moreover, the cell transfer of inhibitory NF-kappaB mutant-infected T(H)2 cells reduced ear thickness in the mite antigen-induced skin lesion of NC/Nga mice. CONCLUSION: Hyperresponsive T(H)2 cells with an enhanced activity of NF-kappaB and AP1 play a crucial role in the pathogenesis of atopic dermatitis-like skin lesions in NC/Nga mice. CLINICAL IMPLICATIONS: These results indicate potential therapeutic usefulness of developing selective inhibitors for NF-kappaB in the treatment of human atopic dermatitis. FAU - Tenda, Yoshiyuki AU - Tenda Y AD - Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan. FAU - Yamashita, Masakatsu AU - Yamashita M FAU - Kimura, Motoko Y AU - Kimura MY FAU - Hasegawa, Akihiro AU - Hasegawa A FAU - Shimizu, Chiori AU - Shimizu C FAU - Kitajima, Masayuki AU - Kitajima M FAU - Onodera, Atsushi AU - Onodera A FAU - Suzuki, Akane AU - Suzuki A FAU - Seki, Nobuo AU - Seki N FAU - Nakayama, Toshinori AU - Nakayama T LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060728 PL - United States TA - J Allergy Clin Immunol JT - The Journal of allergy and clinical immunology JID - 1275002 RN - 0 (Cytokines) RN - 0 (NF-kappa B) SB - IM MH - Animals MH - Cell Differentiation/immunology MH - Cytokines/biosynthesis MH - Dermatitis, Atopic/*immunology/metabolism/*pathology MH - Lymph Nodes/immunology/pathology MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Mice, Inbred Strains MH - Mites/immunology MH - NF-kappa B/*physiology MH - Species Specificity MH - Th1 Cells/cytology/immunology/metabolism/transplantation MH - Th2 Cells/*immunology/*metabolism/transplantation EDAT- 2006/09/05 09:00 MHDA- 2006/10/18 09:00 CRDT- 2006/09/05 09:00 PHST- 2005/12/26 00:00 [received] PHST- 2006/05/16 00:00 [revised] PHST- 2006/05/23 00:00 [accepted] PHST- 2006/09/05 09:00 [pubmed] PHST- 2006/10/18 09:00 [medline] PHST- 2006/09/05 09:00 [entrez] AID - S0091-6749(06)01301-7 [pii] AID - 10.1016/j.jaci.2006.05.024 [doi] PST - ppublish SO - J Allergy Clin Immunol. 2006 Sep;118(3):725-33. doi: 10.1016/j.jaci.2006.05.024. Epub 2006 Jul 28.